Ipatasertib in Patients with Tumors with AKT Mutations: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Sub-protocol Z1K

Autor:	K. Kalinsky, W. Zihan, C. McCourt, E.P. Mitchell, J.J. Wright, L.A. Doyle, R.J. Gray, V. Wang, L.M. McShane, L.V. Rubinstein, D. Patton, P.M. Williams, S.R. Hamilton, B.A. Conley, C.A. Arteaga, L.N. Harris, P.J. O’Dwyer, A.P. Chen, K.T. Flaherty
Rok vydání:	2022
Předmět:	Cancer Research Oncology
Zdroj:	European Journal of Cancer. 174:S8-S9
ISSN:	0959-8049
DOI:	10.1016/s0959-8049(22)00824-3
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::e34fc03d8fd82e7b02d428a8cb24cbd8 https://doi.org/10.1016/s0959-8049(22)00824-3 Zobrazit plný text záznamu Full Text from ScienceDirect